AT385656B - Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid - Google Patents

Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid

Info

Publication number: AT385656B
Authority: AT; Austria
Prior art keywords: cyclic; producing; pharmaceutical composition; nasal administration; ergot peptide
Prior art date: 1982-02-01

Application number

AT0030383A

Other languages

German (de)

English (en)

Other versions

ATA30383A (de

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-01

Filing date

1983-01-31

Publication date

1988-05-10

1983-01-31 Application filed by Sandoz Ag filed Critical Sandoz Ag

1987-10-15 Publication of ATA30383A publication Critical patent/ATA30383A/de

1988-05-10 Application granted granted Critical

1988-05-10 Publication of AT385656B publication Critical patent/AT385656B/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT0030383A 1982-02-01 1983-01-31 Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid AT385656B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8202781		1982-02-01

Publications (2)

Publication Number	Publication Date
ATA30383A ATA30383A (de)	1987-10-15
AT385656B true AT385656B (de)	1988-05-10

Family

ID=10528017

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0030383A AT385656B (de)	1982-02-01	1983-01-31	Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid

Country Status (27)

Country	Link
JP (1)	JPS58134017A (fr)
AT (1)	AT385656B (fr)
AU (1)	AU565613B2 (fr)
BE (1)	BE895750A (fr)
CA (1)	CA1197783A (fr)
CH (1)	CH653555A5 (fr)
DE (1)	DE3302949A1 (fr)
DK (1)	DK164771C (fr)
ES (1)	ES8502865A1 (fr)
FI (1)	FI81258C (fr)
FR (1)	FR2539994B1 (fr)
GR (1)	GR81320B (fr)
HK (1)	HK59989A (fr)
HU (1)	HU191512B (fr)
IE (1)	IE54532B1 (fr)
IL (1)	IL67822A (fr)
IT (1)	IT1197558B (fr)
KE (1)	KE3888A (fr)
LU (1)	LU84613A1 (fr)
MY (1)	MY8700766A (fr)
NL (1)	NL192325C (fr)
NZ (1)	NZ203117A (fr)
PH (1)	PH22198A (fr)
PT (1)	PT76166B (fr)
SE (1)	SE454402B (fr)
SG (1)	SG34389G (fr)
ZA (1)	ZA83673B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0715285D0 (en) *	2007-08-06	2007-09-12	Britannia Pharmaceuticals Ltd	Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) *	2009-06-16	2009-07-29	Biocopea Ltd	Drug composition and its use in therapy
US20190209463A1 (en) *	2018-01-05	2019-07-11	Impel Neuropharma, Inc.	Intranasal delivery of dihydroergotamine by precision olfactory device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3091569A (en) *	1960-08-26	1963-05-28	Mead Johnson & Co	Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
AT287186B (de) *	1966-12-22	1971-01-11	Sandoz Ag	Verfahren zur Herstellung eines neuen Kombinationspräparates hydrierter Mutterkornalkaloide
GB1556851A (en) *	1977-04-12	1979-11-28	Roussel Uclaf	Pharmaceutical compositions
GB1592563A (en) *	1976-11-19	1981-07-08	Sandoz Ltd	Nasal pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2831728C2 (de) *	1978-07-19	1982-12-23	Krewel-Werke Gmbh, 5208 Eitorf	Arzneimittel zur Behandlung von Kopfschmerzen

1983
- 1983-01-25 FI FI830245A patent/FI81258C/fi not_active IP Right Cessation
- 1983-01-27 FR FR8301228A patent/FR2539994B1/fr not_active Expired
- 1983-01-28 PH PH28445A patent/PH22198A/en unknown
- 1983-01-28 NZ NZ203117A patent/NZ203117A/en unknown
- 1983-01-28 NL NL8300325A patent/NL192325C/nl not_active IP Right Cessation
- 1983-01-28 AU AU10850/83A patent/AU565613B2/en not_active Expired
- 1983-01-28 CH CH495/83A patent/CH653555A5/de not_active IP Right Cessation
- 1983-01-29 DE DE19833302949 patent/DE3302949A1/de active Granted
- 1983-01-31 SE SE8300495A patent/SE454402B/sv not_active IP Right Cessation
- 1983-01-31 LU LU84613A patent/LU84613A1/fr unknown
- 1983-01-31 AT AT0030383A patent/AT385656B/de not_active IP Right Cessation
- 1983-01-31 PT PT76166A patent/PT76166B/pt unknown
- 1983-01-31 HU HU83323A patent/HU191512B/hu unknown
- 1983-01-31 JP JP58015392A patent/JPS58134017A/ja active Granted
- 1983-01-31 BE BE1/10708A patent/BE895750A/fr not_active IP Right Cessation
- 1983-01-31 DK DK038183A patent/DK164771C/da not_active IP Right Cessation
- 1983-01-31 CA CA000420539A patent/CA1197783A/fr not_active Expired
- 1983-01-31 GR GR70362A patent/GR81320B/el unknown
- 1983-01-31 IE IE187/83A patent/IE54532B1/en not_active IP Right Cessation
- 1983-02-01 IL IL67822A patent/IL67822A/xx not_active IP Right Cessation
- 1983-02-01 ES ES519450A patent/ES8502865A1/es not_active Expired
- 1983-02-01 IT IT47646/83A patent/IT1197558B/it active
- 1983-02-01 ZA ZA83673A patent/ZA83673B/xx unknown
1987
- 1987-12-30 MY MY766/87A patent/MY8700766A/xx unknown
1989
- 1989-05-25 SG SG343/89A patent/SG34389G/en unknown
- 1989-06-21 KE KE3888A patent/KE3888A/xx unknown
- 1989-07-27 HK HK599/89A patent/HK59989A/xx not_active IP Right Cessation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3091569A (en) *	1960-08-26	1963-05-28	Mead Johnson & Co	Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
AT287186B (de) *	1966-12-22	1971-01-11	Sandoz Ag	Verfahren zur Herstellung eines neuen Kombinationspräparates hydrierter Mutterkornalkaloide
GB1592563A (en) *	1976-11-19	1981-07-08	Sandoz Ltd	Nasal pharmaceutical compositions
GB1556851A (en) *	1977-04-12	1979-11-28	Roussel Uclaf	Pharmaceutical compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AUSTRIA CODEX 1981 1982, ÖSTERREICHISCHER APOTHEKER-VERLAG, WIEN 1981, S. 153, 152, 969 *
IRAVANI J.; MELVILLE G.N.: RESPIRATION 32, 157-164 (1975) *

Also Published As

Publication number	Publication date
KE3888A (en)	1989-09-01
FI81258B (fi)	1990-06-29
FI830245A0 (fi)	1983-01-25
FR2539994B1 (fr)	1986-10-10
MY8700766A (en)	1987-12-31
BE895750A (fr)	1983-08-01
IT8347646A0 (it)	1983-02-01
AU565613B2 (en)	1987-09-24
DE3302949C2 (fr)	1992-05-21
IE830187L (en)	1983-08-01
AU1085083A (en)	1983-08-11
FI830245L (fi)	1983-08-02
GR81320B (fr)	1984-12-11
SE8300495D0 (sv)	1983-01-31
ZA83673B (en)	1984-09-26
NL192325B (nl)	1997-02-03
NL192325C (nl)	1997-06-04
FI81258C (fi)	1990-10-10
DK38183D0 (da)	1983-01-31
FR2539994A1 (fr)	1984-08-03
CH653555A5 (de)	1986-01-15
CA1197783A (fr)	1985-12-10
JPH0253406B2 (fr)	1990-11-16
IE54532B1 (en)	1989-11-08
NZ203117A (en)	1986-12-05
ES519450A0 (es)	1985-02-01
IL67822A0 (en)	1983-06-15
PT76166B (en)	1986-02-04
SE8300495L (sv)	1983-08-02
HK59989A (en)	1989-08-04
DE3302949A1 (de)	1983-08-11
SE454402B (sv)	1988-05-02
DK164771C (da)	1992-12-28
IL67822A (en)	1988-02-29
NL8300325A (nl)	1983-09-01
SG34389G (en)	1989-09-22
IT1197558B (it)	1988-12-06
DK164771B (da)	1992-08-17
ATA30383A (de)	1987-10-15
HU191512B (en)	1987-02-27
ES8502865A1 (es)	1985-02-01
PT76166A (en)	1983-02-01
LU84613A1 (fr)	1983-09-08
DK38183A (da)	1983-08-02
PH22198A (en)	1988-06-28
JPS58134017A (ja)	1983-08-10

Similar Documents

Publication	Publication Date	Title
AT381638B (de)	1986-11-10	Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
AT377438B (de)	1985-03-25	Verfahren zur herstellung einer pharmazeutischen zusammensetzung
ATA164187A (de)	1990-10-15	Verfahren zur herstellung eines pharmazeutischen pulvers
ATA151687A (de)	1994-02-15	Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
ATA904784A (de)	1992-08-15	Verfahren zur herstellung einer mischung aus physiologisch verwendbaren verbindungen
ATA151587A (de)	1994-02-15	Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
ATA170086A (de)	1992-12-15	Verfahren zur herstellung einer festen haltbaren darreichungsform
AT385199B (de)	1988-02-25	Verfahren zur herstellung eines pharmazeutischen praeparates mit verzoegerter wirkstofffreigabe
AT381025B (de)	1986-08-11	Verfahren zur herstellung von topischen pharmazeutischen zubereitungen
AT365451B (de)	1982-01-25	Verfahren zur herstellung einer isosorbiddinitrat enthaltenden pharmazeutischen zubereitung
ATA156187A (de)	1995-06-15	Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
ATA302682A (de)	1986-06-15	Verfahren zur herstellung von neuen cyclischen 9'-thiapeptidergotalkaloiden
ATA254886A (de)	1991-11-15	Verfahren zur herstellung von neuen mitomycin-c-analogen
ATA903983A (de)	1989-04-15	Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
AT388670B (de)	1989-08-10	Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung mit einem gehalt an calciumantagonisten
DE3381345D1 (de)	1990-04-26	Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
ATA541377A (de)	1982-07-15	Verfahren zur herstellung einer pharmazeutischen zusammensetzung
ATA221181A (de)	1983-10-15	Verfahren zur herstellung von einer pharmazeutischen zusammensetzung
AT385656B (de)	1988-05-10	Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid
ATA901886A (de)	1993-02-15	Verfahren zur herstellung von therapeutisch wirksamen ethern polycyclischer verbindungen
DD137670A5 (de)	1979-09-19	Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung
ATA137581A (de)	1983-09-15	Verfahren zur herstellung eines pharmazeutischen praeparates
ATA92982A (de)	1992-06-15	Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin
ATA207887A (de)	1990-08-15	Verfahren zur herstellung eines pharmazeutischen nicorandilpraeparats zur perkutanen absorption
AT383272B (de)	1987-06-10	Verfahren zur herstellung von pharmazeutischen tabletten

Legal Events

Date	Code	Title	Description
2006-06-15	ELA	Expired due to lapse of time